Diabetic Ulcers Treatment Market Size & Share, by Ulcer Type (Foot, Mouth, Other Ulcer); Treatment Type (Wound-Care Dressings, Wound-Care Devices, Active Therapies); End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4585
Published Date: Feb 27, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Diabetic Ulcers Treatment Landscape

Orpyx Medical Technologies Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
PENTAX Medical
Smith & Nephew plc
Organogenesis Inc.
SIGVARIS GROUP
3M
Molnlycke Health Care AB,
Medtronic Plc
Hill-Rom Holdings, Inc.
ConvaTec Inc.

Browse Key Market Insights with Data Illustration:

Diabetic Ulcers Treatment Market Size & Share, Global Forecast Report 2033

In the News

Orpyx Medical Technologies Inc., a company specializing in digital health therapeutics, has launched Orpyx SI Sensory Insoles incorporated with remote patient monitoring technology for the prevention of diabetic foot ulcers (DFUs) and ulcers associated with neuropathy.
As part of its therapeutic accessories portfolio, PENTAX Medical has launched a range of platforms dedicated to electrosurgical and argon plasma coagulation (APC) techniques - the ENDO ARC and ENDO PLUS.

Frequently Asked Questions (FAQ)

Rising Prevalence of diabetes, mouth and foot ulcer, increasing medicare spending along with growing cases of gum diseases are the major factors driving the growth of the diabetic ulcer treatment market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Lack of raw materials and supply due to covid-19 and unawareness about the treatment options for diabetic ulcers are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Medtronic Plc, Hill-Rom Holdings, Inc., ConvaTec Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by ulcer type, treatment type, end user and, by region.

The foot ulcer segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Diabetic Ulcers Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the diabetic ulcer treatment market?

What would be the CAGR of diabetic ulcer treatment market over the forecast period?

What are the challenges affecting the diabetic ulcer treatment market growth?

Which region will provide more business opportunities for growth of diabetic ulcer treatment market in future?

Who are the major players dominating the diabetic ulcer treatment market?

How are the company profiles selected?

What are the segments in the diabetic ulcer treatment market?

Which segment captures the largest market size in ulcer type segment in the diabetic ulcer treatment market?